Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1.
about
Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 diseaseGenomic expression analyses reveal lysosomal, innate immunity proteins, as disease correlates in murine models of a lysosomal storage disorderOmics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism InvestigationsPre-symptomatic activation of antioxidant responses and alterations in glucose and pyruvate metabolism in Niemann-Pick Type C1-deficient murine brainDefective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C DiseaseGpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C DiseaseMitochondrial Gene Expression Profiles and Metabolic Pathways in the Amygdala Associated with Exaggerated Fear in an Animal Model of PTSD.Analytical Characterization of Methyl-β-Cyclodextrin for Pharmacological Activity to Reduce Lysosomal Cholesterol Accumulation in Niemann-Pick Disease Type C1 Cells.Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrinAltered transition metal homeostasis in Niemann-Pick disease, type C1.Cholesterol homeostatic responses provide biomarkers for monitoring treatment for the neurodegenerative disease Niemann-Pick C1 (NPC1)Alterations in gene expression in mutant amyloid precursor protein transgenic mice lacking Niemann-Pick type C1 proteinComprehensive analysis of gene expression profiles of the beet armyworm Spodoptera exigua larvae challenged with Bacillus thuringiensis Vip3Aa toxin.Identification of a biomarker in cerebrospinal fluid for neuronopathic forms of Gaucher disease.Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann-Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis.Corpus callosum diffusion tensor imaging and volume measures are associated with disease severity in pediatric Niemann-Pick disease type C1.Complement is dispensable for neurodegeneration in Niemann-Pick disease type C.Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.Efficacy of N-acetylcysteine in phenotypic suppression of mouse models of Niemann-Pick disease, type C1.Cerebrospinal Fluid Calbindin D Concentration as a Biomarker of Cerebellar Disease Progression in Niemann-Pick Type C1 Disease.Identification of Niemann-Pick C1 disease biomarkers through sphingolipid profilingPlasma signature of neurological disease in the monogenetic disorder Niemann-Pick Type C.Mitochondrial cholesterol: mechanisms of import and effects on mitochondrial function.NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls.Identification of lysosomal Npc1-binding proteins: Cathepsin D activity is regulated by NPC1.HPGCD outperforms HPBCD as a potential treatment for Niemann-Pick disease type C during disease modeling with iPS cells.Increased Regenerative Capacity of the Olfactory Epithelium in Niemann-Pick Disease Type C1.Role of Diffusion Tensor Imaging in Prognostication and Treatment Monitoring in Niemann-Pick Disease Type C1.Normalization of Hepatic Homeostasis in the Npc1nmf164 Mouse Model of Niemann-Pick Type C Disease Treated with the Histone Deacetylase Inhibitor Vorinostat.Geranylgeranyl pyrophosphate is crucial for neuronal survival but has no special role in Purkinje cell degeneration in Niemann Pick type C1 disease.The extending spectrum of NPC1-related human disorders: from Niemann-Pick C1 Disease to obesity.Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease.The susceptibility of cochlear outer hair cells to cyclodextrin is not related to their electromotile activity
P2860
Q27006029-8CBA49D7-EEF1-45A7-AF24-C637D7FBA77CQ27312396-B698B4E1-EFD7-403D-9B47-BCEDF084B06BQ28068009-888C70EF-EC9E-4D31-BD69-2B6D557E31B5Q28393157-84E36976-E1FE-4364-B2E6-08387270F8E3Q28551021-ACE11276-BA17-463C-B28D-F098008C60D7Q28552531-30F8C6CB-1870-4EA5-B729-11DB211358F4Q30587444-2C516E67-F946-40BE-9478-99F12462D2E0Q33903675-D7C65B9E-EF17-45ED-AA67-C46ABF7654C1Q33945068-EB44B1F4-F0CD-4426-8585-6AFDED73E9A9Q34262544-DE028255-E000-4502-A284-52865292F44FQ34379062-C90E205D-B6F0-4C80-AF66-6F3A507B7319Q34575511-1F2F994C-2AF9-4A27-98CA-275059201462Q35061398-30DEC4C5-4C60-4EE9-810E-D60E9C7E7275Q35180647-F5075B3C-F7A4-42FC-8862-7C595C832482Q36103923-262237E4-1DCE-4449-A116-96E37666778FQ36416474-46239D2A-ED4E-41A4-89F2-1AFCABC9990DQ36437350-F0EDFFA1-D1D2-4743-B910-05E0189FEF97Q36774925-64ECE106-9786-41D1-9584-173CBE117CC1Q37078859-AA6F9F51-0F3E-45D6-823F-BC47D0BEAF7CQ37122028-E4B55EEE-97F8-4665-9182-7FF0055D6E49Q37163059-ACE9E24B-671A-4507-8CC9-81D1CAFB87F1Q37653212-78592B38-0C29-4DBD-B3F5-429F34F8097AQ38271508-7BE6D24F-3536-4EBC-8B6B-23E4E98F3DA8Q38652409-A5187B6B-3090-44CC-9ACA-78EFBE85526EQ38824395-ABFCE2D8-0826-4FEC-BDA8-10DB312E1005Q39072413-08096209-155B-46A4-984C-5F737036532BQ41953682-8F40E21B-4C2F-421A-8B52-90F5EE58F1CEQ42112277-A0D02290-75C2-47BD-A11E-84901CDFEAD4Q48379148-1D6D3E39-9D7D-41B3-935F-B01496C47F10Q48484002-2B45EC47-E731-4822-86D6-1D3E1CE2B22DQ50084571-BA10C255-BB19-4AA0-A4E7-79A7EE209175Q51127427-03CD1EC8-CED5-42BF-9999-B856C6C7A455Q58701628-83D222D6-912C-4786-AEF8-5A84C29AA4AB
P2860
Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Microarray expression analysis ...... Niemann-Pick disease, type C1.
@ast
Microarray expression analysis ...... Niemann-Pick disease, type C1.
@en
type
label
Microarray expression analysis ...... Niemann-Pick disease, type C1.
@ast
Microarray expression analysis ...... Niemann-Pick disease, type C1.
@en
prefLabel
Microarray expression analysis ...... Niemann-Pick disease, type C1.
@ast
Microarray expression analysis ...... Niemann-Pick disease, type C1.
@en
P2093
P2860
P50
P356
P1476
Microarray expression analysis ...... Niemann-Pick disease, type C1.
@en
P2093
Bhavesh Borate
Celine V M Cluzeau
Daniel S Ory
Forbes D Porter
Michelle K Dail
Nicole Yanjanin
Steven U Walkley
P2860
P304
P356
10.1093/HMG/DDS193
P577
2012-05-22T00:00:00Z